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data refrained us from drawing conclusions on causality. The 
few studies that reported neuroimaging results found a mi-
nor correlation with cognitive impairment.  Key Messages: 
Mild cognitive impairment is present in more than a third of 
the TIA patients and has a profile comparable with vascular 
cognitive impairment. Reported rates of post-TIA cognitive 
impairment are highly variable and higher frequencies are 
found with cognitive screening tools. Considerable hetero-
geneity and insufficient data limit further conclusions about 
potential causative factors.  © 2016 S. Karger AG, Basel 
 Introduction 
 The symptoms of a transient ischemic attack (TIA) by 
definition subside completely within 24 h  [1–3] . Only 
one-third of the patients have signs of acute infarction on 
diffusion weighted imaging (DWI)  [4] . Despite the tran-
sient nature of focal symptoms associated with TIA and 
the absence of visible brain lesions in most patients, many 
experience persistent cognitive problems afterward  [5] . 
The prevalence of objective cognitive impairment after 
TIA is, however, unclear.
 The post-TIA cognitive profile is unknown, since cog-
nitive assessment is not part of the routine work-up  [6] . 
Unrecognized cognitive dysfunction may affect the qual-
ity of life, highlighting the importance of reliable preva-
 Key Words 
 Transient ischemic attack · Cognitive impairment · 
Prevalence · Cognitive profile · Systematic review 
 Abstract 
 Background: Although by definition a transient ischemic at-
tack (TIA) lasts less than 24 h, many patients experience cog-
nitive complaints beyond focal symptom resolution. How-
ever, their prevalence, causes and profile are unclear. We 
therefore performed a systematic review on cognitive im-
pairment after TIA.  Summary: Medline and Embase were 
searched for relevant studies. Risk of bias was assessed, and 
data synthesis was performed according to the severity of 
cognitive impairment. Thirteen studies were included, with 
considerable heterogeneity concerning methods and tim-
ing of cognitive testing. Confounding, detection bias and at-
trition were the main causes of a high risk of bias in several 
studies. The prevalence of post-TIA mild cognitive impair-
ment ranged from 29 to 68%. Severe cognitive impairment 
was found in 8–22% of patients. Studies using a cognitive 
screening instrument and those performed shortly after TIA 
or several years later, reported the highest frequencies of im-
pairment. Patients evaluated with a screening tool were sub-
stantially older than those who underwent a full neuropsy-
chological assessment (weighted mean age difference 10.9 
years). Based on limited data, the post-TIA cognitive profile 
showed prominent executive function deficits. Insufficient 
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lence estimates of post-TIA cognitive impairment as well 
as knowledge about its profile and potential determinants 
 [7, 8] .
 Symptom severity and infarct location are the main 
disease-related determinants of post-stroke cognitive im-
pairment  [9] . Whether these characteristics also apply to 
TIA is to date unknown. A persistent ischemic lesion after 
TIA might be the substrate for cognitive impairment, but 
the severity of TIA symptoms only weakly corresponds to 
the presence of vascular lesions on neuroimaging  [4] . 
New cerebrovascular events that occur after a TIA might 
also have cognitive consequences, even though they often 
pass without recognized acute clinical symptoms  [10, 11] . 
Vascular risk factors present in TIA patients increase the 
risk of progression of white matter hyperintensities, 
which are associated with cognitive decline as well  [12, 
13] . Moreover, anxiety, depressive symptoms and deliri-
um shortly after TIA can affect cognitive function  [14] .
 We performed a systematic review of the prevalence 
and profile of cognitive impairment in TIA patients. In 
addition, we aimed to assess potentially causative factors.
 Methods 
 Reporting of this systematic review was done in accordance 
with the PRISMA guidelines (checklist provided in online suppl. 
methods; for all online suppl. material, see www.karger.com/
doi/10.1159/000444282)  [15] .
 Data Sources 
 Relevant studies were identified with a literature search of the 
electronic medical databases, Medline and Embase, last performed 
on May 20, 2015. Different medical subject headings and free 
search terms for ‘cognition’ and ‘transient ischemic attack’ were 
combined (search strategy provided in online suppl. methods). In 
addition, reference lists of all included articles were screened to 
identify potentially missed papers.
 Study Selection and Eligibility Criteria 
 The search was limited to studies that had been performed in 
humans. Eligible articles were selected by a 2-step approach. 
First, one reviewer screened titles and abstracts of all retrieved 
records for the following characteristics: (1) original article pub-
lished in English, (2) study concerning TIA patients defined by 
either the classical time-based definition or the newly proposed 
tissue-based definition  [2, 6] and (3) presence of any informa-
tion about cognitive function. From records fulfilling these cri-
teria, full-text articles were obtained. These entered the next step 
of the selection process in which all papers were evaluated 
against the following inclusion criteria: (4) assessment of cogni-
tive function by at least one test, (5) definition of cognitive im-
pairment provided, (6) study concerning only TIA patients or 
results reported separately from other stroke patients and (7) 
time interval between TIA and assessment of cognitive function 
reported. Two authors separately performed the second step of 
the selection process; in case of disagreement, a consensus meet-
ing was held.
 Risk of Bias Assessment 
 Risk of bias assessment was performed with the Research Tri-
angle Institute (RTI) item bank, a tool to evaluate the quality of 
observational studies with a focus on bias and confounding  [16, 
17] . In a recent comparison study, the RTI item bank was found to 
provide a more complete quality assessment than the Newcastle–
Ottawa Scale  [18, 19] . In line with the developer’s instructions, the 
tool was tailored to match the review topic and designs of the in-
cluded studies. Eleven items that assessed the selection bias, detec-
tion bias, attrition bias, selective outcome reporting and con-
founding were selected (online suppl. methods).
 Data Extraction and Synthesis 
 Reported frequencies of cognitive impairment were extracted, 
as were details on study design, inclusion and exclusion criteria, 
demographics, methods and timing of cognitive assessment, brain 
imaging results and vascular risk factors. When present, informa-
tion on domain-specific cognitive performance was recorded.
 Studies were grouped according to the severity of cognitive im-
pairment reported, defined as mild or severe cognitive impairment 
 [20] . Weighted mean age was calculated per study, with weighting 
according to study size. Qualitative synthesis of study results was per-
formed with particular attention to the method and timing of cogni-
tive testing, inclusion of TIA patients with a previous stroke, presence 
of vascular brain lesions, assessment of concurrent neuropsychiatric 
symptoms and judgment of cognitive function before the TIA. Due 
to a large between-study heterogeneity concerning methods and tim-
ing of cognitive testing, as well as inclusion criteria and patient char-
acteristics, quantitative meta-analysis was deemed inappropriate.
 Results 
 Literature Search and Study Selection 
 The literature search yielded 4,058 records, 13 articles 
of which were eligible for inclusion ( fig. 1 ). Twelve studies 
(including 1,167 patients (mean age range 57–74 years)) 
reported the prevalence of mild cognitive impairment 
and 3 studies (including 330 patients (mean age range 
60–74 years)) provided data on the prevalence of severe 
cognitive impairment ( table  1 ). Online supplementary 
table S1 provides additional characteristics of the includ-
ed studies on post-TIA cognitive impairment.
 Study Characteristics and Risk of Bias Assessment 
 All but one study prospectively included consecutive 
eligible patients  [21] . Two studies had a cross-sectional 
design  [22, 23] , 1 was a case–control study  [24] , and 9 
were cohort studies  [25–33] . One study restricted inclu-
sion to patients with symptomatic ipsilateral internal 
 carotid artery occlusion  [25] .
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 Seven studies assessed cognitive function with a neu-
ropsychological test battery (NPS) covering most cogni-
tive domains  [22, 23, 25–27, 29, 30] while the other stud-
ies used brief cognitive screening tools, including the 
Montreal Cognitive Assessment (MoCA), Mini Mental 
State Examination (MMSE) or modified Telephone In-
terview for Cognitive Status (TICSm)  [21, 24, 28, 31–33] . 
The time interval between TIA and cognitive testing var-
ied from several days to 5 years. Different definitions of 
cognitive impairment were used. Studies using a cogni-
tive screening instrument applied previously reported 
cutoff scores, while those performing a NPS used various 
cutoff criteria for a performance below age- and educa-
tion-adjusted normative scores or a control group to de-
fine cognitive impairment ( table 1 ).
 Risk of bias assessment of individual studies showed an 
unclear or high risk of confounding, especially taking into 
account age, level of education, previous stroke and vas-
cular risk factors. Although not invalidating the results of 
individual studies, it increased between-study heteroge-
neity and may as such be an important contributor to the 
large differences in observed rates of post-TIA cognitive 
impairment. To a lesser extent, there was a risk of detec-
tion bias and attrition (online suppl. fig. S1, table S2).
 Prevalence of Cognitive Impairment after TIA 
 The reported rates of mild cognitive impairment after 
TIA were highly variable, ranging from 29 to 68% ( ta-
ble 1 ). Studies using MoCA or TICSm generally reported 
higher frequencies than those applying a NPS, with the 
3,435 records identified through
Medline literature search
3,087 records identified through
Embase literature search
4,058 records after duplicates
removed
71 full-text articles assessed for
eligibility
3,987 excluded after title and abstract screening
58 excluded:
?  Results for TIA patients not (separately) reported (30)
???Time interval from TIA to cognitive testing not reported (18)
???No cognitive test performed (7)
???No definition of cognitive impairment (3)
13 articles inlcuded in qualitative
synthesis
No meta-analysis performed
(too large between-study heterogeneity)
Step 1
Step 2
 Fig. 1. Flowchart of the 2-step approach to the selection of eligible articles on post-TIA cognitive impairment. 
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exception of one study that reported a prevalence of mild 
cognitive impairment of 54% using a NPS in patients 
with an ipsilateral internal carotid artery occlusion  [25] , 
and one study in which only executive function was test-
ed and found to be impaired in 57% of TIA patients  [22] . 
Patients evaluated with a screening tool were substan-
tially older than those who underwent a full neuropsy-
chological assessment (weighted mean age difference 
10.9 years).
 The highest frequencies of impairment were found 
shortly (within 2 weeks) and on the long-term (more than 
1 year) after the qualifying TIA. Only 2 studies specifi-
cally stated that incident stroke between TIA and cogni-
tive testing was an exclusion criterion  [23, 33] .
 Severe cognitive impairment was present in 8–22% of 
patients ( table 1 ). Studies on the prevalence of moderate 
to severe cognitive impairment included older patients 
than those on mild cognitive impairment (weighted mean 
age difference 6.1 years). Only one study used a test bat-
tery to determine severe cognitive impairment  [26] and 
found a higher prevalence than 2 other studies that ap-
plied MMSE  [32, 33] .
 Studies differed considerably in the proportion of pa-
tients with a low level of education, ranging from 26 to 
87%. The definitions of a low level of education also dif-
fered and could have contributed to the between-study 
heterogeneity ( table 1 ). Six studies did not provide any 
information about the educational level of TIA patients 
 [21, 22, 24, 27–29] .
 Profile of Cognitive Function after TIA 
 Two studies performing a NPS provided information 
on the cognitive profile of TIA patients and found prom-
inent impairment in the domains executive function, 
working memory, attention and information processing 
speed  [23, 25] . One study performed a specific test battery 
focused on executive function  [22] . The other studies ei-
ther did not describe the cognitive profile or perform 
MMSE or MoCA. These instruments have not been for-
mally validated for the assessment of specific cognitive 
domains in non-demented patients with cerebrovascular 
disease, although the non-amnestic cognitive impair-
ment detected by these tools is consistent with the neuro-
psychological domains reported to be prominently affect-
ed in cerebrovascular patients  [30, 31, 33–35] .
 Concomitant Cerebrovascular Disease and Structural 
Brain Changes 
 Only 5 studies reported the presence of vascular risk 
factors  [23–25, 28, 33] . The prevalence of hypertension, 
diabetes mellitus, hypercholesterolemia and smoking did 
not differ between these studies (online suppl. table S1). 
Two studies provided information on brain imaging after 
TIA. In one study, inclusion was restricted to patients 
with symptomatic ipsilateral internal carotid artery oc-
clusion. Signs of prior infarction were found in 56–58% 
of patients, while white matter hyperintensities were 
present in 8–15%  [25] . Patients with a previous stroke 
were not excluded in this study and concomitant cerebro-
vascular disease on brain imaging was unrelated to worse 
cognitive function. Another study excluded patients with 
previous stroke and performed either CT or MRI within 
3 weeks after the qualifying event. The median age-relat-
ed white matter changes score  [36] was 1 and silent brain 
infarcts were present in 18% of TIA patients. The latter 
was related to worse executive functioning but could not 
explain the presence of overall cognitive impairment  [23] .
 Concurrent Neuropsychiatric Symptoms 
 All but 2 studies reported that patients with pre-exist-
ing dementia were excluded  [21, 25] . No studies specifi-
cally investigated the relationship between post-TIA cog-
nitive impairment and psychiatric symptoms such as 
anxiety, depression or delirium. One study excluded pa-
tients with current depression  [27] , one adjusted for pos-
sible depression (defined as a Hospital Anxiety and De-
pression Scale, depression subscore  ≥ 8, present in 12%) 
 [23] , one study reported that 9% of patients were treated 
for depression at the time of cognitive testing  [33] and 
one stated that no TIA patients had known pre-existing 
depression  [24] .
 Discussion 
 Main Findings 
 This systematic review shows that post-TIA cognitive 
impairment is frequent, with mild cognitive impairment 
prevalent in 29–68% of patients and severe cognitive im-
pairment in 8–22%. Since nearly all the included studies 
excluded prior dementia and the overall mean age is rela-
tively low, the prevalence rate of cognitive impairment is 
likely higher in the total population with TIA and general-
izability of our results is limited to the non-demented pop-
ulation  [37] . Differences in reported rates of cognitive im-
pairment after TIA are partly explained by differences in 
patient characteristics, methods and timing of cognitive 
testing. Higher frequencies of impairment are found with 
cognitive screening instruments, albeit in a substantially 
older population and within the first weeks after a TIA or 
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several years later. Based on limited data, deficits in execu-
tive function, attention and information processing speed 
appear to be most common. Between-study heterogeneity 
and lack of data impairs the possibilities to determine po-
tential causative factors of post-TIA cognitive impairment.
 Methodological Considerations 
 Considerable heterogeneity existed between studies 
on post-TIA cognitive impairment, limiting the possibil-
ities to combine and meta-analyze results in a quantita-
tive manner. First, classification of cognitive impairment 
was not uniform across studies. A variety of cognitive 
tests were used, ranging from short screening instru-
ments to comprehensive neuropsychological test batter-
ies. In addition, different cutoffs for impairment were ap-
plied. Studies using screening tools included patients who 
were, on an average, substantially older than those in 
studies applying a test battery. Furthermore, information 
about the level of education was often lacking. Since cut-
offs for MoCA and MMSE are not age- and education-
adjusted, this could at least partly explain the structurally 
reported higher frequencies of cognitive impairment in 
studies using these tools compared to those performing 
formal neuropsychological testing, which take age and 
education into account. Differences in test selection may 
not always be a methodological weakness, as long as the 
tests are validated and the assessment encompasses the 
same major cognitive domains (preferably those defined 
by the National Institute of Neurological Disorders and 
Stroke-Canadian Stroke Network vascular cognitive im-
pairment harmonization standards working group, 
namely executive, visuospatial, language and memory 
functions)  [38] . However, the use of different cutoffs for 
cognitive impairment may be a factor that reduces the 
combinability of study results  [30] . That is, while some 
studies applied widely used and generally accepted cutoff 
criteria for cognitive impairment, such as 1.5, 1.65 or 2 SD 
below the age- and education-adjusted normative mean 
on  ≥ 1 cognitive domain (corresponding with percentile 
scores of 5.9, 5.0 and 2.3, respectively), other studies de-
fined cognitive impairment as a performance below 1 SD 
(a percentile of 15.8) or failure on only one test, which is 
typically considered too lenient, increasing the risk of 
false positive results  [39] .
 Second, the small number of eligible studies and lack 
of data on vascular risk factors, brain imaging and con-
current neuropsychiatric symptoms limited the possibil-
ity of identifying possible causes and associated factors of 
cognitive dysfunction after TIA. As none of the included 
studies performed DWI and no study applied the newly 
proposed tissue-based definition of TIA, we were not able 
to determine the influence of DWI-positivity on cogni-
tive outcome and applied the classical time-based TIA 
definition throughout our study  [2, 6] . Furthermore, 
since 4 studies originated from the same population-
based cohort (Oxford Vascular Study)  [40, 41] , we cannot 
rule out the possibility that results partly overlap, al-
though demographics differed between the individual 
study populations  [30–33] . Next, using only papers writ-
ten in English could be a bias. This is however not very 
likely since there is no reason why studies published in 
other languages should report systematically different re-
sults. Finally, the relatively young mean age of the cohorts 
in some studies limits the generalizability of these results 
to the overall TIA population, which is typically older.
 Prevalence of Cognitive Impairment after TIA 
 Compared to the prevalence of cognitive impairment 
in the general population (7% in a Dutch population-
based sample of 55–95 years of age community-dwelling 
persons)  [42] , post-TIA cognitive impairment is consid-
erably more prevalent. It is, however, less prevalent than 
cognitive impairment after stroke, as reported by all but 
one study that performed a head-to-head comparison of 
cognitive function after TIA and stroke  [21, 27, 29–31, 
33] . This is to be expected given the presumably more 
widespread brain damage after stroke. Even when cogni-
tive function after minor stroke (defined as National In-
stitute of Health Stroke Scale  ≤ 3) is compared to TIA, the 
prevalence of impairment after the latter is lower  [31] . 
However, signs of acute infarction are present on DWI in 
up to 30% of TIA patients  [4] . Whether these patients or 
those with longer symptom duration have worse cogni-
tive performance afterward is unknown.
 Large differences in delay were present between TIA 
and cognitive testing. Both studies carried out in the ear-
liest (first weeks) and the late (after several years) phases 
found more patients to be cognitively impaired. Especial-
ly in the early phase, cognitive function can be influenced 
by stress, anxiety or delirium, leading to falsely high rates 
of persistent cognitive impairment. Transient cognitive 
impairment in the first month after TIA appears to be a 
common feature, and although its causes remain to be 
elucidated, patients with transient cognitive impairment 
had worse cognitive outcomes than those without  [32] . 
As all other included studies focused exclusively on fixed 
rather than transient cognitive impairment, the concept 
of dynamic change in cognitive function is a topic that 
merits further research. When tested several years after a 
TIA, incident cerebrovascular events or progressive neu-
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rodegenerative pathology may result in a larger propor-
tion of patients being cognitively impaired. As most stud-
ies did not report whether incident strokes were an exclu-
sion criterion, and since new cerebrovascular lesions 
often pass unnoticed  [43] , these potential causes of the 
higher rates of cognitive impairment in the late phase af-
ter TIA need further study.
 Cognitive Profile after TIA 
 The cognitive profile of TIA patients appears to be con-
sistent with that most often seen in vascular cognitive im-
pairment, with prominent deficits in executive function, 
attention and information processing speed  [44] . How-
ever, this conclusion is based on limited evidence. That is, 
sub-scores of MoCA and MMSE have not been validated 
and may also be insensitive to subtle decrements, as these 
tools have been developed to detect cognitive decline due 
to Alzheimer’s disease  [34] and vascular cognitive impair-
ment is often characterized by a non-amnestic profile, 
driven by subcortical vascular damage disrupting subcor-
tical–frontal connections  [45] . Nevertheless, the cognitive 
profiles detected by MoCA and MMSE are generally in 
line with the results of studies using a NPS, which can be 
considered a form of validation  [30, 31, 33] .
 Potential Causes and Underlying Mechanisms 
 Cognitive dysfunction after TIA can be explained in 
several ways, none of which can be confirmed on the ba-
sis of the currently reviewed literature. A TIA could, de-
spite the transient nature of the focal symptoms, cause 
permanent brain damage, thereby disrupting networks 
involved in cognitive processes and leading to cognitive 
impairment  [46] . This theory is however only partly sup-
ported by DWI studies, in which signs of recent infarction 
are found in about 30% of clinically defined TIA patients 
 [4] . Furthermore, we recently showed that the clinical di-
agnosis of TIA may be inadequate, as more than 20% of 
patients not fulfilling the clinical criteria for TIA were 
found to have DWI lesions compatible with recent infarc-
tion  [47] . This issue touches on the matter of the newly 
proposed, tissue-based definition of TIA, which discrim-
inates between patients with and without signs of recent 
infarction on brain imaging and states that only the latter 
category truly meets the criteria for TIA. Patients with 
imaging signs of recent infarction are considered to have 
had brain infarction, regardless of symptom duration  [6] . 
The relatively high prevalence of cognitive impairment 
after TIA suggests that some non-focal symptoms may 
not be as transient as the focal neurological symptoms 
and as such provides an additional argument for this re-
consideration of the diagnosis of TIA. Further studies are 
needed to identify whether there is a difference in cogni-
tive outcome between patients with DWI-positive and 
DWI-negative TIA.
 In addition, impaired cognitive function might have 
been present prior to TIA. Both TIA and cognitive impair-
ment can result from the same underlying cerebrovascular 
disease process. Cerebral vascular damage including silent 
brain infarcts and white-matter hyperintensities of pre-
sumed vascular origin may lead to cognitive impairment 
and dementia  [12, 13, 48] . Moreover, anxiety, depressive 
symptoms and delirium can occur after TIA and negative-
ly influence cognitive function  [49] . Although partly tran-
sient, these psychiatric disturbances may be a major cause 
of cognitive impairment when assessed shortly after TIA.
 Conclusion 
 Cognitive impairment is remarkably prevalent in TIA 
patients. This contrasts with the lack of regular cognitive 
evaluation in TIA patients and urges attention to the pos-
sibility of persistent cognitive problems after seemingly 
completely subsided neurological symptoms. This sys-
tematic review shows a lack of available data on factors 
associated with cognitive impairment after TIA. Future 
studies preferably include brain imaging and evaluate 
both concomitant vascular risk factors and neuropsychi-
atric disturbances. In addition, to further determine the 
consequences of post-TIA cognitive impairment, assess-
ment of subjective cognitive complaints both by patients 
and caregivers is important, in addition to comprehen-
sive neuropsychological assessment using sensitive tests. 
Cognitive impairment is present in at least one-third of 
the TIA patients, which justifies scientific ventures to fur-
ther identify this previously overlooked group at in-
creased risk of cognitive decline.
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